Scientist Solutions: International Life Science Community By Scientists For Scientists
    
Home » Societies » The Biotech Research Society of India Forum

The Biotech Research Society of India Forum

Thanks to our sponsors who make this site possible
Welcome Members and guests. Our Forum is brought to you through our partnership with Scientist Solu-
tions.com which manages these pages to promote the free exchange of useful scientific information. We
encourage you to dive in and join the conversation!

How do I use this forum?
Registered members can create new topics and reply to topics from other users. To learn more about s-
uccessful posting in the forums Click Here. Subscribing to Society Sub-forums will keep you informed
and involved.
Disclaimer - The The Biotech Research Society of India Society supports the free exchange of scientific information, but is not responsible or liable for comments made in public forums such as this one. Topics and posts deemed unsuitable will be moderated and removed.


The Biotech Research Society of India Subforums

RSS Feed
Sub-forumsTopics  Replies  ViewsLast Post

Strategies to Identify Drug Targets/Biomarkers

Biomarkers
22 23 36095

Urgent Dilution problem! Please hel ...


by Saluferkimo
May 21, 2015, 15:24 PM

Target Validation Techniques

Target Validation Techniques
9 9 24614

WHY LIPIDS NOT PAID MORE ATTENTION?


by skarthikumar
Nov 09, 2012, 11:02 AM

Pharmacokinetics

Extent and rate of absorption, distribution, metabolism and excretion ( ADME)
18 46 53400

piclamilast


by Debbie Reed Bietz
Jun 25, 2012, 11:25 AM

Bioprocessing/Scale Up and Isolation

Fermentation, cell culture, expression, and recovery
22 27 37603

isolating dna from spotted on filte ...


by Pippuri
May 04, 2015, 16:26 PM

Good Manufacturing/Validation Practice (GMP/GVP)

Control and management
24 51 51916

Performance Qualification (PQ) of L ...


by Eibhor
Aug 17, 2015, 21:01 PM

Equipment

Pharmacology equipment
18 49 47312

How to choose your system Fiber opt ...


by Idealphotonics
Oct 05, 2015, 6:41 AM

Assay Development & Protocols

Also, remember to visit the protocols tab on the homepage toolbar
48 46 59937

Xanthine Oxidase Inhibitory Assay


by Paye
Feb 27, 2012, 20:34 PM



Society Overview

The aims & objectives of the Biotech Research Society [BRSI] are:
  • To promote the R&D in biotechnology in India
  • To bring interaction between the academic institutes and the biotech industries, interact with the industries and help them in resolving their problems, as well make them aware with the latest developments in the biotech sector
  • To provide and arrange the training in biotechnology, dissemination of biotech knowledge through the organization of the lectures, seminars and symposia on the scientific programmes and societal missions.

Contact Society Forum Organizer
Society Organizer: Ashok Pandey

Click here to
Become a member & join our
community (It's easy & free)
Already a member? Please log in
User Name  
Password  
Forget Password?
News Feeds from
BioTech News
Biotech news continually updated from thousands of sources around the net.

The Biotechnology Innovation Organization today announces preliminary programing for the upcoming BIO CEO & Investor Conference to be held February 12-13, 2018 in New York. The program will include a diverse group of industry luminaries at the forefront of exciting science in such areas as gene therapy and new oncology treatments.

Net Savings Link, Inc. -- a medical technology and software company, announced today that its subsidiary, Shanghai based Vital Strategic Research Institute , has signed an agreement with Eli Lilly and Company. Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease among newly diagnosed diabetes patients at increased risk of CVD in China.

Aurora Cannabis Inc. . Healthcare. Down 24 cents, or 3.31 per cent, to $7.00 on 7.2 million shares.

Kuala Lumpur: Technology Park Malaysia Corporation Sdn Bhd , a company owned by the Ministry of Finance, is calling existing and budding Johorean entrepreneurs and technopreneurs to leverage on its infrastructure, facilities and services in order to penetrate global markets. The Kuala Lumpur-based company, which is operating under the auspices of the Ministry of Science, Technology and Innovation, said it was the only fourth generation incubation model that offered specialised advisory, as well as, a comprehensive and integrated entrepreneurship and technopreneurship development programme.

Edwards Lifesciences Corporation - Equities research analysts at Leerink Swann increased their Q2 2018 earnings per share estimates for shares of Edwards Lifesciences in a research note issued to investors on Friday. Leerink Swann analyst D. Antalffy now anticipates that the medical research company will post earnings per share of $1.12 for the quarter, up from their prior forecast of $1.01.

The London-listed satellite company Avanti Communications will take a big step towards shrinking its mammoth debts on Wednesday when it unveils plans to hand bondholders a $550m equity stake. Sky News has learnt that Avanti, which is one of a number of stock market-quoted businesses wrestling with a glut of new satellite capacity, is to announce proposals for a big debt-for-equity swap.

This Monday, May 23, 2016, file photo, shows the Bayer AG corporate logo displayed on a building of the German drug and chemicals company in Berlin. Monsanto is rejecting Bayer's $62 billion takeover bid, calling it "incomplete and financially inadequate.

Wright Medical Group and Delcath Systems are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, institutional ownership and profitability. Delcath Systems has lower revenue, but higher earnings than Wright Medical Group.

On November 28, 2017, the PTAB issued a final written decision upholding the patentability of U.S. Patent No. 6,667,061 .

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Acorda Therapeutics, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit )--The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States Distri... )--The "The Complete Microsoft Office 2010 Training Bundle - A super pack of 23 DVDs" training has been added to Research and Markets' offering.

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced new results from two studies with EndoPredict are being featured at the 2017 San Antonio Breast Cancer Symposium in San Antonio, Texas. EndoPredict is a second-generation prognostic gene expression test for patients with breast cancer.

On December 5, 2017, the Federal Circuit heard oral argument in Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company , 17-1694.

After taking GlaxoSmithKline's Paxil for just two days, retired oilman Don Schell brutally murdered his wife, daughter and 10-month-old granddaughter in the middle of the night before turning the gun on himself. The murders, which took place in 1998 in Gillette, Wyoming, shocked neighbors who couldn't understand why Schell, who had no history of violence, appeared to have spontaneously killed the people in his life he loved the most.

A U.S. Senator is criticizing the director of Centers for Disease Control and Prevention for an apparent financial conflict of interest that the senator says may prevent the director from doing her job. Dr. Brenda Fitzgerald became director of the Atlanta-based CDC in July, and was required to sell a range of stocks she owned, including beer and soda companies, the tobacco company Philip Morris International, and a number of health care companies such as vaccine manufacturers and health-care companies.

In this Oct. 16, 2014 file photo, Brenda Fitzgerald, Georgia Department of Public Health commissioner, left, and Georgia Gov. Nathan Deal respond to questions in Atlanta. Fitzgerald, the new director of the Atlanta-based Centers for Disease Control and Prevention, has kept a low profile during her five months in office, due to conflicts of interest regarding her financial holdings.

In this Oct. 16, 2014 file photo, Brenda Fitzgerald, Georgia Department of Public Health commissioner, left, and Georgia Gov. Nathan Deal respond to questions in Atlanta. Fitzgerald, the new director of the Atlanta-based Centers for Disease Control and Prevention, has kept a low profile during her five months in office, due to conflicts of interest regarding her financial holdings.

A street-level rendering of the planned new headquarters for General Electric in South Boston, which has been delayed by the new CEO as the company runs into problems in its new home. A street-level rendering of the planned new headquarters for General Electric in South Boston, which has been delayed by the new CEO as the company runs into problems in its new home.

Thank You to Our Sponsor